Abstract The oncological and functional outcomes in glioblastoma (GBM) patients following supratotal resection (SupTR), involving complete of contrast-enhancing enhanced (CE) tumors areas methionine (Met) uptake on 11 C-met positron emission tomography (Met-PET), are unknown. We conducted a retrospective review newly diagnosed, IDH1 wild-type GBM patients, comparing SupTR with gross total (GTR)...
